[go: up one dir, main page]

NO20083035L - Enzymer for redusert immunologisk stress - Google Patents

Enzymer for redusert immunologisk stress

Info

Publication number
NO20083035L
NO20083035L NO20083035A NO20083035A NO20083035L NO 20083035 L NO20083035 L NO 20083035L NO 20083035 A NO20083035 A NO 20083035A NO 20083035 A NO20083035 A NO 20083035A NO 20083035 L NO20083035 L NO 20083035L
Authority
NO
Norway
Prior art keywords
animal
compositions
enzymes
level
animal feed
Prior art date
Application number
NO20083035A
Other languages
English (en)
Other versions
NO340818B1 (no
Inventor
David M Anderson
Humg-Yu Hsiao
Lin Liu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20083035L publication Critical patent/NO20083035L/no
Publication of NO340818B1 publication Critical patent/NO340818B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SAMMENDRAG Det tilveiebringes sammensetninger egnet for oral administrasjon til et dyr, omfattende minst ett stressdempende enzym i en mengde effektiv for å minske nivået av 5 positivt akuttfaseprotein hos et dyr, øke nivået av negativt akuttfaseprotein hos et dyr og/eller forbedre vekstytelsen i dyret samt fremgangsmåter som anvender slike sammensetninger. Sammensetningene omfatter dyrefôrsammensetninger, flytende sammensetninger annet enn dyrefôr og faste sammensetninger annet enn dyrefôr.
NO20083035A 2005-12-15 2008-07-09 Sammensetninger for oral administrasjon til dyr omfattende enzymer for redusert immunologisk stress NO340818B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75033905P 2005-12-15 2005-12-15
PCT/US2006/047592 WO2007075343A2 (en) 2005-12-15 2006-12-14 Enzymes for reduced immunological stress

Publications (2)

Publication Number Publication Date
NO20083035L true NO20083035L (no) 2008-09-11
NO340818B1 NO340818B1 (no) 2017-06-26

Family

ID=38218427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083035A NO340818B1 (no) 2005-12-15 2008-07-09 Sammensetninger for oral administrasjon til dyr omfattende enzymer for redusert immunologisk stress

Country Status (35)

Country Link
US (5) US7914782B2 (no)
EP (2) EP1973561B1 (no)
JP (1) JP5189989B2 (no)
KR (2) KR101454032B1 (no)
CN (3) CN105831428B (no)
AR (1) AR057247A1 (no)
AT (1) ATE497779T1 (no)
AU (1) AU2006329927B2 (no)
BR (1) BRPI0620155B1 (no)
CA (1) CA2633066C (no)
CL (1) CL2011000941A1 (no)
CR (1) CR10116A (no)
DE (1) DE602006020074D1 (no)
DK (1) DK1973561T3 (no)
EC (1) ECSP088578A (no)
ES (1) ES2361819T3 (no)
GT (1) GT200600512A (no)
HN (1) HN2008000906A (no)
HR (1) HRP20080319B1 (no)
IL (2) IL192088A (no)
IN (1) IN2008DE06112A (no)
MX (1) MX284326B (no)
MY (1) MY145870A (no)
NO (1) NO340818B1 (no)
NZ (1) NZ569186A (no)
PE (1) PE20070840A1 (no)
PL (1) PL1973561T3 (no)
PT (1) PT1973561E (no)
RU (1) RU2465005C2 (no)
SI (1) SI1973561T1 (no)
SV (1) SV2008002942A (no)
TW (2) TWI402039B (no)
UA (1) UA95266C2 (no)
WO (1) WO2007075343A2 (no)
ZA (1) ZA200805780B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2633066C (en) * 2005-12-15 2015-01-20 Chemgen Corporation Enzymes for reduced immunological stress
AU2013219820B2 (en) 2012-02-16 2015-02-26 Elanco Us Inc. Methods and compositions for reducing the environmental impact of animal waste
EP3030093B1 (en) * 2013-07-26 2017-09-06 Novozymes A/S POLYPEPTIDES HAVING alpha-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
US10392639B2 (en) * 2014-03-21 2019-08-27 Dsm Ip Assets B.V. Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase
CN106771257A (zh) * 2017-01-24 2017-05-31 北京美正生物科技有限公司 一种检测血清淀粉样蛋白a的酶联免疫吸附试剂盒及其制备方法和用途
CN107156522A (zh) * 2017-06-23 2017-09-15 都匀市山郎科技养殖有限公司 一种鸡饲料
BE1030865B1 (nl) * 2022-09-12 2024-04-09 Nu3Guts Bv Voederadditief voor het verbeteren van de darmgezondheid en/of de verteerbaarheid van voeder in vee
WO2025099136A2 (en) * 2023-11-10 2025-05-15 Kerry Group Services International Limited Nucleases in animal feed

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201949A (ja) * 1982-05-17 1983-11-25 Kyodo Shiryo Kk 家畜用配合飼料
US5372939A (en) * 1991-03-21 1994-12-13 The United States Of America As Represented By The United States Department Of Energy Combined enzyme mediated fermentation of cellulous and xylose to ethanol by Schizosaccharoyces pombe, cellulase, β-glucosidase, and xylose isomerase
JP2942384B2 (ja) * 1991-06-07 1999-08-30 株式会社ヤクルト本社 飼料効率改善添加剤
GB2261877A (en) * 1991-11-21 1993-06-02 Kyowa Hakko Kogyo Kk Animal feed additive comprising enzyme and amino acid
WO1995005455A1 (en) * 1993-08-13 1995-02-23 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
US5861271A (en) * 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
DE69524951T3 (de) * 1994-04-22 2009-07-09 Novozymes A/S Verfahren zum verbessern der löslichkeit von pflanzlichen proteinen
GB9416841D0 (en) * 1994-08-19 1994-10-12 Finnfeeds Int Ltd An enzyme feed additive and animal feed including it
NL1003096C2 (nl) 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JP2001057852A (ja) * 1995-06-14 2001-03-06 Showa Denko Kk 耐熱酵素含有飼料用組成物
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
ATE217153T1 (de) * 1995-11-06 2002-05-15 Novozymes As Verwendung von galactanase in tierfutter
AU2568697A (en) 1996-04-12 1997-11-07 Novo Nordisk A/S An enzyme with beta-1,3-glucanase activity
US6162473A (en) 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US20020164751A1 (en) * 1996-06-19 2002-11-07 Short Jay M. Enzymes having thermostable phosphatase activity and methods of use thereof
GB9623539D0 (en) 1996-11-12 1997-01-08 Biotal Ltd Enzymes and their use
GB2327345B (en) 1997-07-18 1999-06-23 Finnfeeds Int Ltd Use of an enzyme for manufacturing an agent for controlling bacterial infection
US6022566A (en) 1997-12-02 2000-02-08 Balchem Corporation Method for increasing the feed intake, feed efficiency, daily gain and/or carcass grade in ruminants
EP0976838A1 (en) * 1998-05-06 2000-02-02 Rhone-Poulenc Nutrition Animale Enzymes mixture
US6331426B1 (en) * 1999-02-11 2001-12-18 Novozymes A/S Bacterial galactanases and use thereof
US6213930B1 (en) 1999-03-15 2001-04-10 Wisconsin Alumni Research Foundation Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency
US6500658B1 (en) * 1999-08-17 2002-12-31 Novozymes, A/S Xyloglucanase from Malbranchea
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
GB0010748D0 (en) 2000-05-05 2000-06-28 Brown Paul D Tricep exercise horse (fold up and portable)
US20020095135A1 (en) * 2000-06-19 2002-07-18 David Meeker Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
GB2371013B (en) 2001-01-16 2004-06-09 Terry John Claydon Copying apparatus
US20040078842A1 (en) * 2001-01-17 2004-04-22 Aviah Zilberstein Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
DE10105306A1 (de) * 2001-02-02 2002-08-22 Nutrinova Gmbh Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
CN1622761A (zh) * 2002-01-25 2005-06-01 Dsmip资产公司 热稳定酶组合物
WO2005000195A2 (en) * 2002-11-13 2005-01-06 Rosenberg Yvonne J A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
WO2004054609A1 (en) * 2002-12-12 2004-07-01 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20110142817A1 (en) * 2004-02-04 2011-06-16 Pharmaaware Sepsis B.V. Means and method for treating and/or preventing necrotizing enterocolitis
US8574863B2 (en) * 2004-02-04 2013-11-05 Pharmaaware Sepsis B.V. Alkaline phosphatase for treating an inflammatory disease of the gastro-intestinal tract
EP1740204B1 (en) * 2004-04-01 2018-03-14 Chiesi Farmaceutici S.p.A. Medicinal use of alpha-mannosidase
WO2006099699A1 (en) * 2005-03-25 2006-09-28 Universiteit Gent Enzymatic demethylation of flavonoids
CN1699576A (zh) * 2005-06-30 2005-11-23 江南大学 一种内切β－1,3葡聚糖酶基因及其克隆方法
WO2007032818A2 (en) * 2005-09-12 2007-03-22 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
CA2633066C (en) * 2005-12-15 2015-01-20 Chemgen Corporation Enzymes for reduced immunological stress
CA2716400C (en) * 2008-02-29 2017-05-09 Alloksys Life Sciences B.V. Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases

Also Published As

Publication number Publication date
KR101399205B1 (ko) 2014-05-27
CN105831428A (zh) 2016-08-10
US7914782B2 (en) 2011-03-29
CN102293323A (zh) 2011-12-28
NO340818B1 (no) 2017-06-26
CA2633066A1 (en) 2007-07-05
WO2007075343A2 (en) 2007-07-05
US20070141041A1 (en) 2007-06-21
US20110177195A1 (en) 2011-07-21
KR101454032B1 (ko) 2014-10-27
GT200600512A (es) 2007-06-28
HRP20080319A2 (hr) 2008-12-31
SV2008002942A (es) 2008-12-03
ES2361819T3 (es) 2011-06-22
CN105831428B (zh) 2020-12-01
MX284326B (en) 2011-03-01
KR20080081972A (ko) 2008-09-10
JP5189989B2 (ja) 2013-04-24
AU2006329927B2 (en) 2011-09-29
US8778648B2 (en) 2014-07-15
UA95266C2 (uk) 2011-07-25
EP2263685A3 (en) 2011-04-06
AR057247A1 (es) 2007-11-21
EP1973561A2 (en) 2008-10-01
SI1973561T1 (sl) 2011-07-29
US20110171344A1 (en) 2011-07-14
ECSP088578A (es) 2008-10-31
NZ569186A (en) 2011-09-30
US20170156371A1 (en) 2017-06-08
KR20130082514A (ko) 2013-07-19
DK1973561T3 (da) 2011-05-23
PT1973561E (pt) 2011-05-12
IN2008DE06112A (no) 2008-09-26
MX2008007735A (en) 2008-08-27
CL2011000941A1 (es) 2014-08-08
MY145870A (en) 2012-05-15
ZA200805780B (en) 2009-03-25
US20110171345A1 (en) 2011-07-14
TWI619506B (zh) 2018-04-01
BRPI0620155B1 (pt) 2015-07-21
EP2263685A2 (en) 2010-12-22
RU2465005C2 (ru) 2012-10-27
HRP20080319B1 (hr) 2015-11-20
CN101374544A (zh) 2009-02-25
BRPI0620155A2 (pt) 2011-11-01
RU2008128583A (ru) 2010-01-20
CR10116A (es) 2008-10-28
EP1973561B1 (en) 2011-02-09
TWI402039B (zh) 2013-07-21
DE602006020074D1 (de) 2011-03-24
PL1973561T3 (pl) 2011-08-31
CA2633066C (en) 2015-01-20
IL192088A0 (en) 2009-02-11
CN101374544B (zh) 2016-05-18
PE20070840A1 (es) 2007-08-25
JP2009519712A (ja) 2009-05-21
TW201336425A (zh) 2013-09-16
TW200731932A (en) 2007-09-01
IL192088A (en) 2013-07-31
WO2007075343A3 (en) 2007-10-04
AU2006329927A1 (en) 2007-07-05
HN2008000906A (es) 2011-07-12
IL227318A (en) 2016-11-30
ATE497779T1 (de) 2011-02-15

Similar Documents

Publication Publication Date Title
NO20083035L (no) Enzymer for redusert immunologisk stress
NO20075077L (no) Fremgangsmate for a forbedre laering og hukommelse i pattedyr
CN103472235A (zh) 一种长效蛋白质溶液稳定剂
WO2010020475A3 (de) Verfahren zur verbesserung der reinigungsleistung eines wasch- oder reinigungsmittels
EA200870538A1 (ru) Лиофилизированные композиции анти-egfr антител
EA201001558A1 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ anr NOX-ИНГИБИТОРЫ ДЛЯ ПОДАВЛЕНИЯ АКТИВНЫХ ФОРМ КИСЛОРОДА
EA200870264A1 (ru) Композиция антител
Nobbs et al. Genetics of sanguinis-group streptococci in health and disease
BRPI0516323A (pt) construtos de rna
RU2008126743A (ru) Способ получения фармацевтической композиции
DK1448229T3 (da) Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr
AR036322A1 (es) Metodos y composiciones para sacarificacion y fermentacion simultaneas
MX2009010492A (es) Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped.
NO20065232L (no) 8-(2-hydroksyfenoksy)oktyldietanolamin og salter derav for avlevering av aktive forbindelser
NO20065084L (no) Interferon-alfa polypeptider og konjugater
NO20054362L (no) Polyalkenaminer med forbedrete bruksegenskaper
MX421703B (es) Gh5 y gh30 en molienda en humedo.
PT1276763E (pt) Proteinas anti-congelantes sua producao e utilizacao
WO2004011637A3 (en) Modified adamts4 molecules and method of use thereof
Chen et al. Beneficial effects of astragalus polysaccharides treatment on cardiac chymase activities and cardiomyopathy in diabetic hamsters
Takahashi et al. Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarction
Liang et al. Rice protein reduces DNA damage by activating the p53 pathway and stimulating endogenous antioxidant response in growing and adult rats
FR3055215B1 (fr) Composition comprenant des extraits de pollen et /ou de pistils
WO2013033366A3 (en) Methods and compositions for promoting glucose homeostasis
NO20100060L (no) Kosttilskudd

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ELANCO US INC., US